Literature DB >> 12787644

The preparation of agglomerates containing solid dispersions of diazepam by melt agglomeration in a high shear mixer.

Anette Seo1, Per Holm, Henning Gjelstrup Kristensen, Torben Schaefer.   

Abstract

The aim of this study was to prepare by melt agglomeration agglomerates containing solid dispersions of diazepam as poorly water-soluble model drug in order to evaluate the possibility of improving the dissolution rate. Lactose monohydrate was melt agglomerated with polyethylene glycol (PEG) 3000 or Gelucire 50/13 (mixture of glycerides and PEG esters of fatty acids) as meltable binders in a high shear mixer. The binders were added either as a mixture of melted binder and diazepam by a pump-on procedure or by a melt-in procedure of solid binder particles. Different drug concentrations, maximum manufacturing temperatures, and cooling rates were investigated. It was found to be possible to increase the dissolution rate of diazepam by melt agglomeration. A higher dissolution rate was obtained with a lower drug concentration. Admixing the binders by the melt-in procedure resulted in similar dissolution rates as the pump-on procedure. The different maximum manufacturing temperatures and cooling rates were found to have complex effects on the dissolution rate for formulations containing PEG 3000, whereas only minor effects of the cooling procedure were found with Gelucire 50/13. Gelucire 50/13 resulted in faster dissolution rates compared to PEG 3000.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787644     DOI: 10.1016/s0378-5173(03)00228-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Preparation and in vitro evaluation of polystyrene-coated diltiazem-resin complex by oil-in-water emulsion solvent evaporation method.

Authors:  Arindam Halder; Biswanath Sa
Journal:  AAPS PharmSciTech       Date:  2006-05-26       Impact factor: 3.246

2.  High-performance lithium-ion anodes using a hierarchical bottom-up approach.

Authors:  A Magasinski; P Dixon; B Hertzberg; A Kvit; J Ayala; G Yushin
Journal:  Nat Mater       Date:  2010-03-14       Impact factor: 43.841

3.  Inclusion of Digestible Surfactants in Solid SMEDDS Formulation Removes Lag Time and Influences the Formation of Structured Particles During Digestion.

Authors:  Kapilkumar Vithani; Adrian Hawley; Vincent Jannin; Colin Pouton; Ben J Boyd
Journal:  AAPS J       Date:  2017-01-23       Impact factor: 4.009

4.  Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug.

Authors:  Tejal J Shah; Avani F Amin; Jolly R Parikh; Rajesh H Parikh
Journal:  AAPS PharmSciTech       Date:  2007-04-13       Impact factor: 3.246

5.  Preparation and in-vitro evaluation of indomethacin nanoparticles.

Authors:  A Rezaei Mokarram; A Kebriaee Zadeh; M Keshavarz; A Ahmadi; B Mohtat
Journal:  Daru       Date:  2010       Impact factor: 3.117

Review 6.  Solvent-free melting techniques for the preparation of lipid-based solid oral formulations.

Authors:  Karin Becker; Sharareh Salar-Behzadi; Andreas Zimmer
Journal:  Pharm Res       Date:  2015-03-19       Impact factor: 4.200

Review 7.  Twin-Screw Melt Granulation for Oral Solid Pharmaceutical Products.

Authors:  Seth P Forster; Erin Dippold; Tiffany Chiang
Journal:  Pharmaceutics       Date:  2021-05-06       Impact factor: 6.321

8.  An investigation on the solid dispersions of chlordiazepoxide.

Authors:  Ali Nokhodchi; Roya Talari; Hadi Valizadeh; Mohammad Barzegar Jalali
Journal:  Int J Biomed Sci       Date:  2007-09

Review 9.  Lipid-Based Drug Delivery Systems.

Authors:  Hina Shrestha; Rajni Bala; Sandeep Arora
Journal:  J Pharm (Cairo)       Date:  2014-05-19

10.  An attempt to stabilize tanshinone IIA solid dispersion by the use of ternary systems with nano-CaCO3 and poloxamer 188.

Authors:  Hong-Mei Yan; Zhen-Hai Zhang; Yan-Rong Jiang; Dong-Mei Ding; E Sun; Xiao-Bin Jia
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.